Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNAPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZSCAN9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNAB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2E-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ELOVL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGEF37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PREP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOLLIP-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPUSD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYBL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETFDH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRR22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZC3H7B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on